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Intact human epidermis resists invasion by patho-
genic microbes but the biochemical basis of its
resistance is not well understood. Recently, an anti-
microbial peptide, human b-defensin-2, was dis-
covered in in¯amed epidermis. We used a
recombinant baculovirus/insect cell system to pro-
duce human b-defensin-2 and con®rmed that at
micromolar concentrations it has a broad spectrum
of antimicrobial activity, with the striking exception
of Staphylococcus aureus. Immunostaining with a poly-
clonal antibody to human b-defensin-2 showed that
the expression of human b-defensin-2 peptide by
human keratinocytes required differentiation of the
cells (either by increased calcium concentration or
by growth and maturation in epidermal organotypic
culture) as well as a cytokine or bacterial stimulus.
Interleukin-1a, interleukin-1b, or live Pseudomonas
aeruginosa proved to be the most effective stimuli
whereas other bacteria and cytokines had little or no
ability to induce human b-defensin-2 synthesis. In
interleukin-1a-stimulated epidermal cultures, human
b-defensin-2 ®rst appeared in the cytoplasm in differ-
entiated suprabasal layers of skin, next in a more
peripheral web-like distribution in the upper layers
of the epidermis, and then over a few days migrated
to the stratum corneum. By semiquantitative
Western blot analysis of epidermal lysates, the
average concentration of human b-defensin-2 in
stimulated organotypic epidermal culture reached
15±70 mg per gram of tissue, i.e., 3.5±16 mM, well
within the range required for antimicrobial activity.
Because of the restricted pattern of human b-defen-
sin-2 distribution in the epidermis, its local concen-
tration must be much higher. Defensins and other
antimicrobial peptides of in¯amed epidermis are
likely to play an important antimicrobial role in host
defense against cutaneous pathogens. Key words: anti-
microbial peptides/innate immunity/skin infections. J
Invest Dermatol 118:275±281, 2002
E
pithelia that cover body surfaces constitute a barrier to
infection by surrounding microbes. Skin in particular is
constantly exposed to injury and challenged by
environmental microorganisms. In normal hosts, how-
ever, the deeper layers of skin remain free of infections,
suggesting that skin has an innate ability to ®ght invading microbes.
Interesting clues to epidermal innate immunity have been provided
in lower vertebrates by the example of the highly exposed aquatic
organisms. Fish (Cole et al, 2000) and amphibian skin (Simmaco
et al, 1998) are known to be rich sources of numerous and diverse
antimicrobial peptides that are believed to play an essential role in
the defense against the numerous aqueous microbes (Goraya et al,
2000). Despite important structural differences, human skin displays
a protective ability comparable to that observed in the skin of these
lower vertebrates, and indeed, recent studies have demonstrated the
presence of antimicrobial peptides in human skin (reviewed by
Gallo and Huttner, 1998).
Antimicrobial peptides are found in both the plant and animal
kingdoms, where they are regarded as key elements of innate
immunity (Borregaard et al, 2000). These gene-encoded antibiotics
are small and cationic molecules characterized by an amphipatic
structure (Martin et al, 1995). They are able to inactivate a wide
spectrum of microorganisms, mainly by forming pores or other
disruptive structures that permeabilize microbial membranes. The
most common human antimicrobial peptides belong to the a- and
b-defensin families, which differ from one another by the spacing
and connectivity of their six cysteine residues (Ganz and Weiss,
1997). a-Defensins are found in storage granules of specialized cell
types such as neutrophils or the small intestine Paneth cells, whereas
b-defensins are characteristic of epithelial tissues. Human b-
defensin-1 (hBD-1) is highly expressed in the kidney, and to a
lesser extent in pancreas, salivary gland, airway epithelia, female
urogenital system, and placenta (Zhao et al, 1996; Valore et al,
1998). Human b-defensin-2 (hBD-2) expression is reported in
skin, urogenital tract, trachea, and lung (Harder et al, 1997; Bals et
al, 1998; Hiratsuka et al, 1998; Liu et al, 1998).
hBD-2 was originally isolated from the desquamated scales of
psoriatic skin (Harder et al, 1997), suggesting that this defensin may
be involved in cutaneous defense and in¯ammation. To investigate
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the role of hBD-2 in skin immunity, we examined a model of human
epidermis for hBD-2 gene expression and protein production.
MATERIALS AND METHODS
Production and puri®cation of recombinant hBD-2 Recombinant
hBD-2 (rhBD-2) was produced in recombinant baculovirus-infected
insect cells according to the procedure previously described for hBD-1
(Valore et al, 1998). Total RNA isolated from human small airway
epithelial cells was used as a template for reverse transcription and
polymerase chain reaction (RT-PCR). The oligonucleotides hBD-2-UP,
5¢-GGGATCCGCTCCCAGCCATCAGCCATG-3¢, and hBD-2-DW,
5¢-AGCGAATTCAGCTTCTTGGCCTCCTCATG-3¢, speci®c for
hBD-2 cDNA ampli®cation, were used as upstream and downstream
primer, respectively. The PCR product was cloned into the pBacPAK9
transfer vector (Clontech, Palo Alo, CA). After double-strand DNA
sequencing, the selected clone was cotransfected into the insect
Spodoptera frugiperda Sf21 cells with Bsu 361-digested BacPAK6 viral
DNA. The recombinant baculovirus was isolated and tested for rhBD-2
production, and the producing clones were selected to infect Trichoplusia
ni Hi5 cells. The culture media were harvested 96 h after infection and
subjected to cation exchange on a CM Macro-Prep ion exchange resin
(Biorad). Elution was performed with 5% acetic acid (20 min, 4°C). The
lyophilized eluate was ®nally puri®ed by reverse phase high performance
liquid chromatography (HPLC) on a 4.6 3 250 mm Vydac C18 column
(Separations Group, Hesperia, CA) where it eluted at 37% acetonitrile.
Peptide purity was monitored on a silver-stained acid-urea
polyacrylamide gel (Valore et al, 1998).
Mass spectrometry measurements by matrix-assisted laser
desorption/ionization time of ¯ight mass spectrometry (MALDI-
TOF-MS) Twenty nanograms of HPLC-puri®ed rhBD-2 (1 ml) were
loaded on a thin layer of a-cyano-4-hydroxycinnamic acid crystals
(Sigma, Aldrich) made by fast evaporation of a saturated solution in 80%
acetonitrile. The droplets were allowed to dry before introduction into
the mass spectrometer. MALDI-TOF-MS was carried out at the UCLA
Mass Spectroscopy Facility on a Voyager reverse phase mass spectrometer
(PerSeptive BioSystems, Framingham, MA) operating in a positive linear
mode.
Production of polyclonal antibodies against hBD-2 Two
milligrams of HPLC-puri®ed rhBD-2 were coupled to ovalbumin
(Sigma, Aldrich) in a 1:1 mass ratio after activation with 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide (Pierce, Rockford, IL). The puri®ed
conjugate was used to immunize rabbits by six intradermal injections at
30 d intervals with 400 mg of the ovalbumin-coupled hBD-2. The
immune sera were validated in enzyme-linked immunoassay and in
Western blots against rhBD-2, and used as anti-hBD-2 polyclonal
antibodies.
To test the speci®city of anti-hBD-2 serum, we antigen-blocked it
with excess rhBD-2. Brie¯y, 200 ml of serum was mixed with 10 mg of
rhBD-2 for 2 h, diluted to 1 ml total with phosphate-buffered saline
(PBS), and ultracentrifuged at 174,000g for 1 h to remove precipitate.
Mock-extracted serum was prepared in the same manner substituting
diluent for rhBD-2.
Microbial strains and antimicrobial assays The microbial strains
used in this study, including the Gram-negative bacteria Escherichia coli
ML35p (ampicillin-resistant strain) and Pseudomonas aeruginosa ATCC
9027, the Gram-positive Streptococcus agalactiae, Staphylococcus epidermidis,
and S. aureus ATCC 6341, and the fungus Candida albicans 820, were
kindly provided by Robert I. Lehrer (UCLA, School of Medicine, Los
Angeles, CA). Peptide activity was assayed according to the previously
described procedure (Porter et al, 1997). Brie¯y, microorganisms were
grown to exponential growth phase, and adjusted to an input
concentration of 5 3 106±107 cells per ml for S. epidermidis, S. aureus, S.
agalactiae, and P. aeruginosa, or 105±5 3 105 cells per ml for E. coli
ML35p and C. albicans. The microbial suspensions were then incubated
with 0±50 mM rhBD-2, under low-salt (10 mM Na phosphate, pH 7.4,
0.03% TSB), or high-salt (low-salt with 100 mM NaCl added)
conditions. After a 1 h incubation at 37°C, the suspensions were plated
on agar plates to quantitate surviving microbes and were incubated
overnight at 37°C until colonies became visible.
Cell and tissue cultures
Keratinocytes Pooled normal human neonatal epidermal keratinocytes
were obtained from Clonetics (Walkersville, MD) and propagated in
KGM serum-free medium (Clonetics) at 37°C in a CO2 incubator. Cells
were passaged by trypsinization. Calcium concentration of KGM
medium (0.15 mM) was altered by addition of CaCl2 to 1.3 mM.
Organotypic epidermal cultures EpiDerm System organotypic cultures were
obtained from MatTek (catalog #201-AF-AB, Ashland, MA). The
cultures grown from normal human epidermal keratinocytes on collagen-
coated Millicell CM membranes (0.45 mm pores, 24-well size) were
placed in 12-well plates at the air±liquid interface with 1.2 ml EPI-201-
AB-AF medium (1.8 mM Ca2+) provided by MatTek. Cultures were
incubated at 37°C in a CO2 incubator and medium was changed every
2 d.
Stimulated cultures
Cytokine and endotoxin stimulation Cultures of keratinocytes and
epidermis were stimulated by the addition of 10±100 ng per ml
recombinant human cytokines [interleukin-1a (IL-1a), IL-1b, and
tumor necrosis factor a (TNF-a)], purchased from R&D Systems
(Minneapolis, MN) and Peprotech (Rocky Hill, NJ), or E. coli 055:B5
lipopolysaccharide (LPS) (Sigma, Aldrich) into the culture medium. The
LPS stimulation was also performed in the presence of 5% fetal bovine
serum. Stimulation of keratinocytes was performed in eight-well glass
chamber slides from LAB-TEK (Naperville, IL), whereas organotypic
cultures were stimulated in a 12-well plate by replacing the medium
under the membrane inserts. Keratinocytes were maintained for 5 d, and
epidermis for up to 6 d after stimulation.
Microbial stimulation Heat-killed (100°C, 20 min) or live microorganisms
in stationary growth phase were washed with PBS and resuspended in
EPI-201-AB-AF culture medium at a concentration of 106 cells per ml.
Ten microliters of each microbial suspension were spread onto the air-
exposed surface of the epidermal culture and the treated cultures were
incubated for another 48 h. EPI-201-AB-AF medium in which bacteria
were grown overnight was ®ltered (0.2 mm) and spread on epidermal
cultures in the same assay conditions to test the effect of bacterial
secretions alone, compared to fresh EPI-201-AB-AF medium. After
challenge, all cells and tissues were incubated at 37°C in a CO2
incubator, collected at various times, and treated for protein/RNA
extraction as described below.
Immunohistochemistry, light, and epi¯uorescence microscopy
Immunochemical staining was performed as described previously (Valore
et al, 1998). Brie¯y, cells and tissues were ®xed in 3.7% formaldehyde in
PBS. For immunoperoxidase staining, sectioned tissues (4±6 mm sections)
and permeabilized cells were treated for endogenous peroxidase
inactivation (0.1 M periodic acid followed by 0.02% sodium
borohydride). Specimens were then blocked and incubated overnight
with primary antibody. Anti-hBD-2 primary antibody was used at a
1:500±1:1000 dilution. In some experiments, hBD-2-extracted anti-
hBD-2 antibody, or another antidefensin antibody (anti-HNP1-3, Ganz
et al, 1985) raised in the same manner against a similar but not
crossreacting antigen, were used as negative controls at the same dilution.
Anti-human keratinocyte transglutaminase antibody (mouse monoclonal
IgG2a, clone B.C1), obtained from Biomedical Technologies
(Stoughton, MA) was used at a 1:20 dilution. For peroxidase detection,
the specimens were washed and incubated overnight with 0.4 mg per ml
horseradish-peroxidase-conjugated goat antirabbit IgG secondary
antibody (Pierce) and developed in 0.6 mg per ml diaminobenzidine.
For alkaline phosphatase (AP) detection, we used 1:2000 dilution of AP-
conjugated goat antirabbit IgG (Pierce), and developed in Fast Red TR/
Naphthol AS-MX with levamisole (Sigma). For ¯uorescence detection,
Texas-Red-conjugated goat antirabbit IgG antibody, or ¯uorescein-
conjugated horse antimouse IgG antibody (Vector Laboratories,
Burlingame, CA), or ¯uorescein-conjugated horse antimouse IgG
antibody (Pierce) were used at a concentration of 5 mg per ml. After a
90 min incubation, specimens were mounted in Vectriol (Vector
Laboratories) for observation by epi¯uorescence microscopy.
Washes were made in 0.05% Tween 20, 500 mM NaCl, 20 mM
Tris±HCl pH 7.5, or PBS. Antibody dilution buffers included the
addition of 1% gelatin or 3% bovine serum albumin (BSA, Sigma). All
steps were performed at room temperature.
Protein extraction, electrophoresis, and Western blot analysis
Organotypic cultures were separated from the inert support membranes
and homogenized in lysis buffer [130 mM glycine, 2% sodium dodecyl
sulfate (SDS), 7.7% glycerol in 70 mM Tris±HCl, pH 8.8] by repeated
passage through a 26 gauge needle. Media conditioned by the cultures
were adjusted to lysis buffer conditions. Samples in lysis buffer were
boiled for 5 min and loaded directly onto a 16.5% SDS-tricine
polyacrylamide gel (Schagger and von Jagow, 1987). Transfer to
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Immobilon-PSQ membranes (Millipore, Bedford, MA) was performed
for 1 h at 0.18 A in 0.05 M sodium borate, pH 9.0, with 20% methanol
and 0.05% SDS, and immunodetection was performed as described
earlier (Valore et al, 1998), with anti-hBD-2 antibodies used at a 1:1000
dilution, or antihuman keratin 10 antibody (mouse monoclonal IgG1
tissue culture supernatant; DAKO DE-K10, Denmark) at a 1:200
dilution.
RNA extraction and northern blot analysis Total RNA was extracted
from Epiderm cultures using Trizol reagent (BRL, Life Technologies).
Ten to 15 mg of each sample were loaded for RNA electrophoresis on a
1% agarose gel containing 17% formaldehyde and transferred to Hybond-
N ®lter membranes (Amersham). A cDNA probe for hBD-2 was
generated by PCR ampli®cation of hBD-2 cDNA with the oligo-
nucleotides hBD-2-UP and hBD-2-DW described above and subsequent
radiolabeling using the Prime-It RmT labeling kit (Stratagene). The mem-
branes were hybridized at 52°C for 12 h with the [32P]-labeled probes
fragment in a solution containing 50% formamide, 5 3 sodium citrate/
chloride buffer (SSC), 8 3 Denhardt's solution, 0.05 M sodium phosphate
pH 6.5, 0.1% SDS, and 100 mg per ml denatured salmon sperm. The
®lters were washed in 1 3 SSC, 0.1% SDS at 65°C followed by
autoradiography. After stripping with 0.1% SDS at 100°C, the membranes
were rehybridized in the same conditions with a probe corresponding to
[32P]-labeled b-actin cDNA (MTN control probe, Clontech).
RESULTS
Activity of recombinant hBD-2 Recombinant hBD-2
produced by baculovirus expression in Hi5 insect cells was
isolated from the culture medium (see Materials and Methods) and
subjected to MALDI-TOF-MS for purity control and molecular
mass measurement. A single peptide species at MH+ = 4328.45
was identi®ed in the sample (Fig 1), in agreement with the
calculated mass (4328.18 Da). After puri®cation to homogeneity,
the production yield for rhBD-2 was estimated at 1 mg per liter of
culture medium.
The activity of the recombinant peptide was then assayed in the
range of 0±30 mM against the yeast C. albicans and the bacteria E.
coli ML35p, P. aeruginosa, S. agalactiae, S. epidermidis, and S. aureus.
Antimicrobial activity was detected against all six tested strains after
1 h incubation of microorganism with rhBD-2 (Fig 2). A dose-
dependent microbicidal effect was observed for hBD-2, starting at
concentrations from 1 to 3 mM, against all the tested strains with
the exception of S. aureus where rhBD-2 was at most bacteriostatic
in the range of concentrations tested. The microbicidal effect was
reduced (S. epidermidis, E. coli ML35p) or changed to a static effect
(S. agalactiae, C. albicans) under high-salt concentrations (100 mM
NaCl). Data for P. aeruginosa are only given under high-salt
conditions as the bacteria did not grow in low-salt medium.
Induction of hBD-2 production in keratinocyte cultures
Immune serum to hBD-2 was used in immunohistochemistry
experiments to analyze hBD-2 expression in human primary
keratinocytes induced with cytokines or bacterial endotoxin.
Cultures stimulated with 100 ng per ml IL-1a or IL-1b
demonstrated intense hBD-2 staining in a rare subpopulation of
cells (Fig 3A, C), whereas no immunoreactivity could be detected
in cultures stimulated with the same concentrations of TNF-a or
LPS (Fig 3F, G). Addition of fetal bovine serum to LPS
stimulation did not induce detectable amounts of hBD-2 protein
(data not shown). Nonstimulated keratinocytes used as controls did
not show reactivity with the anti-hBD-2 serum.
Localization of hBD-2 protein to differentiated keratino-
cytes In stimulated keratinocyte cultures, hBD-2 protein was not
detected uniformly in all cells. Cells staining for hBD-2 protein
were rare, large, polygonal cells in areas of higher cell density and
multiple cell layers (Fig 3). We hypothesized that these cells were
the more differentiated keratinocytes in the culture. To test this
Figure 2. Antimicrobial activity of rhBD-2
against S. epidermidis, S. aureus, S. agalactiae,
E. coli ML35p, P. aeruginosa, and C. albicans.
The number of CFU was determined after a 1 h
incubation with rhBD-2. Experiments made in
low-salt or high-salt concentrations are indicated
by black and open squares, respectively. Controls
containing peptide solvent only (0.01% acetic
acid) are also shown for incubation times of 0 and
1 h. If CFU concentrations changed signi®cantly
during incubation with solvent only, arrows
indicate whether the CFU increased or decreased
compared to inoculum. Error bars indicate standard
deviations of the mean of triplicate experiments.
Figure 1. Recombinant hBD-2 analysis. MALDI-TOF spectrum of
the rhBD-2 after puri®cation by reversed phase HPLC. Masses are given
as MH+ values.
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hypothesis, we stimulated keratinocyte cultures grown at lower
density with IL-1a in the presence of low (0.15 mM) and high
(1.3 mM) calcium concentrations to induce keratinocyte
differentiation. Cultures were stained for both hBD-2 and
keratinocyte transglutaminase, a membrane associated protein
found in differentiated layers of epidermis (Thacher, 1989), and
then were photographed by epi¯uorescence microscopy. Cells
displaying transglutaminase staining were more numerous at high
calcium concentration (Fig 4). Similarly, increase in calcium
concentration increased the number of keratinocytes staining for
hBD-2 in culture induced with IL-1a. The induced hBD-2
staining was localized in the transglutaminase-positive
keratinocytes.
Production of hBD-2 in keratinocyte organotypic culture
We next examined hBD-2 production in a model of epidermal
differentiation, a keratinocyte organotypic culture created by
growing nontransformed human keratinocytes on an inert
membrane at the air±liquid interface. Under these conditions, the
keratinocytes differentiate into an epidermis-like culture
demonstrating a basal layer, a granular layer, and a stratum
corneum (Fig 5A), and expressing markers of epidermal
differentiation (Klausner et al, 1998). Keratinocyte organotypic
cultures were stimulated with 100 ng per ml IL-1a, and hBD-2
expression was analyzed by immunohistochemistry on epidermis
sections at various times after stimulation (Fig 5). After 2 d of
induction, hBD-2 was seen in all layers of the culture except for the
basal layer (less differentiated cells). The lack of basal cell staining is
particularly well seen in Fig 5(D). In the lower cell layers, hBD-2
staining appeared to be cytoplasmic, whereas in upper cell layers,
staining appeared at the membrane or the exterior of the cell. At 4 d
of induction, hBD-2 was detected in the upper keratinocytes of the
culture and in the stratum corneum. Finally, at 6 d of induction,
hBD-2 was located predominantly in the stratum corneum. Similar
results were found with 20 ng per ml IL-1a and 100 ng per ml IL-
1b stimulation (data not shown). Noninduced organotypic cultures
demonstrated minimal to low levels of hBD-2 staining.
Organotypic culture lysates were analyzed by Western blot for
hBD-2 protein expression. Immunoreactivity in the extracts was
found to be associated with a protein with the same size as rhBD-2
Figure 4. The effect of calcium-induced
differentiation of keratinocytes on hBD-2
and tranglutaminase expression. Keratinocytes
were cultured in low calcium (0.15 mM) and high
calcium (1.30 mM) concentrations with 100 ng
per ml IL-1a or control medium for 5 d.
Fluorescein staining (green) was used for
transglutaminase detection and Texas Red staining
(red) for hBD-2 detection. Immunostained cells
were photographed under epi¯uorescence
microscopy.
Figure 3. Immunostaining of stimulated
keratinocyte cultures with anti-hBD-2
antibody. Keratinocytes stimulated for 3 d with
100 ng per ml IL-1a (A, B), 100 ng per ml IL-1b
(C), 100 ng per ml TNF-a (F), or 100 ng per ml
LPS (G) were grown and ®xed on cytoslides and
immunostained using anti-hBD-2 polyclonal
antibodies with peroxidase detection (brown
staining product). IL-1a-stimulated keratinocytes
stained with preimmune serum (D) and
unstimulated keratinocytes stained with anti-hBD-
2 (E) are shown for comparison. Cells were
photographed under light microscopy with a 103
objective except for panel B, which was
photographed under 403. Panels D±G are shown
half size. Scale bar: (A, C) 100 mm; (B) 25 mm.
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(Fig 6). The immunoreactive band observed in the IL-1a-induced
culture is almost undetectable in the noninduced culture, whereas
both samples show identical immunoreactivity to the control
keratin-10 antibodies. By comparison to standards, the amount of
hBD-2 per lane of stimulated organotypic culture after 2 d appears
to be between 1 and 5 ng, i.e., 15±70 mg per gram of tissue.
Assuming that the density of the epidermal tissue is 1 g per ml, the
concentration of hBD-2 in the stimulated culture can be estimated
at 3.5±16 mM. From a faint hBD-2 signal detected by Western blot
of conditioned medium from induced culture, the total amount of
hBD-2 found in the medium is about 1/5±1/10 of the amount
detected in the tissue.
We next analyzed the effect of IL-1a stimulation (10 ng per ml)
on hBD-2 mRNA expression in the organotypic cultures. Total
RNA extracted from the epidermal cultures was analyzed by
northern blot using the 32P-labeled hBD-2 cDNA as a probe. After
stimulation, there is an increase in hBD-2 mRNA concentration
over 48 h, with detectable hybridization signal present already at 6
h (Fig 7a). As the hybridization signal with hBD-2 mRNA
intensi®es over the 48 h time-course, the observed size decreases,
consistent with poly-A shortening seen with stable mRNA
maturation. RNA from noninduced cultures used as a control
did not display hybridization with the hBD-2 cDNA probe.
Secondary hybridization with a 32P-labeled probe corresponding to
b-actin and used to normalize the signals showed in contrast a
decrease in signal intensity over time with no changes in
electrophoretic behavior.
We next tested the effect of live microorganisms on hBD-2
expression by spreading them on the air-exposed Epiderm surface.
After 48 h of infection, only the P. aeruginosa strain was able to
induce a signi®cant increase in hBD-2 mRNA concentration in the
epidermis (Fig 7b). In samples challenged with other microbes,
hBD-2 mRNA concentrations were similar to sterile medium
control.
DISCUSSION
We have prepared a recombinant version of hBD-2, the recently
identi®ed epidermal antimicrobial peptide, and demonstrated its
in vitro antimicrobial activities. We then showed the dependence of
hBD-2 expression in keratinocytes on the dual factors of differen-
tiation and cytokine or microbial stimulation. We have also shown
that the concentration in stimulated epidermis reaches levels
necessary for antimicrobial activity.
Baculovirus expression of rhBD-2 allowed us to obtain 1 mg
recombinant peptide per liter of initial cell culture medium after a
one-step HPLC puri®cation procedure. This yield is comparable to
that obtained previously for other human defensins expressed in the
same system (Porter et al, 1997; Valore et al, 1998). MALDI-TOF
analysis of rhBD-2 demonstrated that this expression system and
puri®cation procedure were adapted to the preparation of a pure
Figure 5. hBD-2 expression in IL-1a-induced
epidermal cultures. Epidermal cultures were
observed at 2, 4, and 6 d after stimulation with
100 ng per ml IL-1a. (A) Sections of IL-1a-
induced epidermal cultures were stained with
hematoxylin and eosin. BL, GL, SC, and MB
stand for basal layer, granular layer, stratum
corneum, and support membrane, respectively. In
some sections, the membrane was lost during
processing. (B) IL-1a-induced epidermal cultures
were immunoperoxidase stained for hBD-2 and
developed in diaminobenzidine, with no
counterstain. Adjacent sections treated identically
except for preimmune serum substituted for anti-
hBD-2 did not show staining (data not shown).
(C) Sections of noninduced epidermal cultures
stained as in (B). (D) Sections prepared as in (B)
were immunostained for hBD-2, developed with
Fast Red TR/Naphthol AS-MX, and
counterstained with hematoxylin. (E) Same as (D)
but anti-hBD-2 antibody was blocked with excess
hBD-2. (F) Same as (D) but antibody to human
neutrophil defensins hNP1±3 was substituted for
anti-hBD-2. (G) Higher magni®cation of an IL-
1a-induced epidermal culture from day 2,
immunoperoxidase stained for hBD-2. Numbers
indicate the various locations of hBD-2: (1) in the
cytoplasm of a suprabasal keratinocyte; (2) at the
cell periphery in the granular layer keratinocytes;
and (3) in the stratum corneum at day 6 of
stimulation.
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folded rhBD-2 displaying the correct primary sequence (as
indicated by a mass measurement in perfect agreement with the
calculated mass). The activity spectrum of rhBD-2 covered a broad
range of microorganisms including bacteria (both Gram-negative
and Gram-positive) and fungi identi®ed as human pathogens.
Except for one strain (S. aureus) this antimicrobial activity was
shown to be microbicidal at concentrations > 1 mM. As also
reported by Bals et al (1998), we observed that rhBD-2 was less
active at high-salt concentrations. However, substantial rhBD-2
antimicrobial activity remains at salt concentrations (100 mM)
higher than those found in human sweat (20±60 mM) (Lentner,
1981), which is in equilibrium with the salt concentration in upper
keratinocyte layers.
We used polyclonal antibody to rhBD-2 to study hBD-2
expression in skin at the peptide level. We observed that the
cytokines IL-1a and IL-b induced hBD-2 synthesis in keratinocyte
and epidermal cultures. The ®ndings were con®rmed at the
mRNA level in epidermal cultures. In this system, IL-1a
stimulation induces a rapid appearance of hBD-2 mRNA (within
the ®rst 3 h), which then tends to slowly accumulate (up to 48 h) as
indicated by the decreasing size of the mRNA on northern blots
(consistent with the known shortening of the poly-A tail in stable
maturing mRNAs). This rapid increase in mRNA concentration,
together with the identi®cation of NF-kB-like binding motifs in
the hBD-2 gene promoter region (Liu et al, 1998), suggests
transcriptional control of hBD-2 expression by IL-1a and IL-b
(activators of NF-kB) in skin, and is in agreement with the
expression of hBD-2 in in¯ammatory skin disorders but not in
normal skin (Harder et al, 1997).
Although TNF-a has been reported to stimulate hBD-2
expression in keratinocyte cultures (Harder et al, 1997) and
respiratory epithelia (Harder et al, 2000), in our hands this cytokine
did not induce keratinocytes to produce hBD-2 peptide. We also
did not detect LPS induction of hBD-2, which had been reported
in oral mucosa (Mathews et al, 1999). The lack of response to LPS is
not due to the absence of LPS-binding protein as addition of serum
did not induce hBD-2 expression. It is possible that in vivo LPS that
penetrates deep into the skin may activate hBD-2 expression
through macrophages or Langerhans cells serving as intermediates
for LPS detection and production of cytokines that stimulate
hBD-2 expression in differentiated keratinocytes.
Although LPS did not induce hBD-2 expression in our
conditions, epidermal cultures responded to live microbes.
Induced expression of hBD-2 was evidenced by northern blots,
showing a high responsiveness of epidermal cultures to P.
aeruginosa. The activation of hBD-2 expression may be mediated
by P. aeruginosa exotoxins or secretion system. Indeed, some Gram-
negative bacteria such as Helicobacter pylori are able to activate NF-
kB in epithelial cells by their type IV secretion system (for review
see Naumann, 2000). Interestingly, a recent study has demonstrated
that P. aeruginosa type IV pilus was necessary to activate host genes
in infected epithelial cells whereas LPS had only very limited effect
(Ichikawa et al, 2000). Such type IV secretion system functioning
only in live bacteria could be responsible for the activation of hBD-
2 transcription. The lack of response of organotypic epidermal
keratinocytes to LPS and most tested bacteria points to the potential
importance of other cell types (macrophages, dendritic cells, mast
cells, etc.) in initiating cutaneous responses to these agents. IL-1
produced by the latter cells could serve as a potent host defense
activation signal for keratinocytes.
In IL-1a-stimulated primary keratinocyte cultures, hBD-2 was
selectively detected in large and polygonal cells that we identi®ed as
possible differentiated keratinocytes. We con®rmed that cultures
induced to differentiate with high calcium concentrations produced
higher quantities of hBD-2 in response to IL-1a stimulation. The
cellular colocalization of hBD-2 and transglutaminase [used as a
reporter of differentiated keratinocytes (Thacher, 1989)] indicates
that hBD-2 expression is favored in the more mature keratinocytes.
Figure 6. Western blot analysis of hBD-2 expression in epidermal
cultures induced with IL-1a. Epidermal cultures were stimulated with
20 ng per ml IL-1a for 2 d, and then homogenized in lysis buffer as
described. Extracts originating from 75 mg epidermal culture, or aliquots
of conditioned media corresponding to 30 mg of epidermal culture, were
loaded into the indicated lanes. The indicated amounts of rhBD-2 were
used as standards. Samples were separated on nonreducing SDS-tricine
polyacrylamide gel and analyzed by Western blot for hBD-2 or human
keratin-10. Stimulated and nonstimulated cultures are indicated with (+)
and (±), respectively. The locations and sizes (kDa) of molecular weight
markers are shown. Note that uncharacterized high molecular weight
protein bands crossreacting with anti-hBD-2 antibody are observed in
both skin extracts and media but they are not affected by IL-1a
stimulation.
Figure 7. Northern blot analysis of hBD-2 expression in
stimulated epidermal cultures. (A) IL-1a stimulated cultures (10 ng
per ml in culture medium) were analyzed for hBD-2 expression at 0, 6,
19, and 48 h after stimulation. Total RNA samples were loaded at 15 mg
per lane. (B) Cultures were stimulated by spreading 10 ml of live
microbes (106 per ml) or culture medium onto the epidermal surface.
Lanes M, SA, EC, PA, and CA contain lysates of epidermis exposed to
fresh medium, S. aureus, E. coli ML35p, P. aeruginosa, and C. albicans,
respectively. Positive controls were exposed to IL-1a or IL-1b in the
culture medium; in the negative control (NS) only the saline solvent was
added to the culture medium. Total RNA was extracted after 48 h and
loaded at 12 mg per lane. Blots were successively hybridized with 32P-
labeled hBD-2 and b-actin cDNA.
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This ®nding parallels the localization of hBD-2 to the differen-
tiated suprabasal layers of skin in IL-1a-stimulated epidermal
cultures. Over time, hBD-2 migrates from the suprabasal layers to
the stratum corneum. The localization of hBD-2 in the cell
cytoplasm in lower layers and then at the keratinocyte periphery as
cells move closer to the surface suggests that hBD-2 is secreted onto
the cell membrane or into the intercellular space and ®nally
concentrates in the dehydrated cells of the epidermal surface (days
4±6). Such a hypothesis is in agreement with the presence of a
signal peptide in the hBD-2 precursor sequence (Harder et al,
1997). Compared to the amount of hBD-2 in stimulated epidermis,
less hBD-2 was detected in the corresponding culture medium.
This difference could be due to the ef®cient retention of hBD-2
within the epidermis. We cannot exclude the possibility that the
inert membrane also absorbs a fraction of the secreted peptide,
however, or that our system predominantly measures products
secreted downward through the basal layer of the epidermis.
Importantly, the calculated epidermal hBD-2 concentration of 3.5±
16 mM falls within its antimicrobial range, and as the volume of
distribution is probably restricted to the intercellular space, the local
concentrations could be much higher. If so, hBD-2 could serve its
antimicrobial function in skin by concentrating in spaces exposed to
microbial invasion such as the intercellular space or the epidermal
surface. It is important to note that the known chemotactic activity
of hBD-2 for immature dendritic cells and memory T cells (Yang
et al, 1999) requires much lower concentrations than its
antimicrobial activity and thus the relevant chemotactic concen-
trations could be reached even quicker. The inducibility of hBD-2
production by IL-1 and live P. aeruginosa suggests a dynamic system
that can be rapidly activated in response to infections.
In concert with hBD-2, antimicrobial peptides such as the
cathelicidin hCAP18/LL-37 (Frohm et al, 1997), and to a lesser
extent the b-defensin hBD-1 (Boe et al, 1999), were shown to be
expressed in keratinocytes, and like hBD-2, hCAP18/LL-37
expression may be increased by in¯ammation. Additional anti-
microbial activity was also attributed to other factors expressed in
skin such as the antileukoprotease (Wiedow et al, 1998). Together,
the antimicrobial peptides of human skin are likely to provide an
effective shield from microbial infection.
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